Intubation secondary to asthma exacerbation in a patient with asthma receiving Xolair (omalizumab).
Zachary D
ZD
Jacobs
Jesus R
JR
Guajardo
D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007442:Intubation, Intratracheal; D008297:Male; D000069444:Omalizumab; D012121:Respiration, Artificial / Q000295:instrumentation; D013997:Time Factors; D017211:Treatment Failure
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab